BANK VONTOBEL/PUT/CVS HEALTH/65/0.1/20.09.24 Share Price

Warrant

DE000VM5PJZ3

Delayed Deutsche Boerse AG 11:14:11 24/06/2024 pm IST
0.5 EUR -9.09% Intraday chart for BANK VONTOBEL/PUT/CVS HEALTH/65/0.1/20.09.24
Current month-33.33%
1 month-45.05%
Date Price Change
24/24/24 0.5 -9.09%
21/24/21 0.55 -1.79%
20/24/20 0.56 +1.82%
19/24/19 0.55 +3.77%
18/24/18 0.53 -7.02%

Delayed Quote Deutsche Boerse AG

Last update June 24, 2024 at 11:14 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VM5PJZ
ISINDE000VM5PJZ3
Date issued 17/11/2023
Strike 65 $
Maturity 20/09/2024 (88 Days)
Parity 10 : 1
Emission price 0.44
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.14
Lowest since issue 0.079
Spread 0.05
Spread %9.43%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
61.73 USD
Average target price
69.1 USD
Spread / Average Target
+11.93%
Consensus